NASAL INNOVATION FORUM 2025

A Concrete Commitment to Advancing Nasal Drug Delivery Innovation Sterling is proud to be a co-organizing partner of the Nasal Innovation Forum 2025.
Sterling is honored to be a co-organizer of the Nasal Innovation Forum 2025, scheduled for September 18–19 at the Trenton Country Club (New Jersey, USA). In collaboration with IPAC-RS (International Pharmaceutical Aerosol Consortium on Regulation and Science), this international forum will bring together leading voices to advance innovation in nasal drug delivery systems.
Sterling is honored to be a co-organizer of the Nasal Innovation Forum 2025, scheduled for September 18–19 at the Trenton Country Club (New Jersey, USA). In collaboration with IPAC-RS (International Pharmaceutical Aerosol Consortium on Regulation and Science), this international forum will bring together leading voices to advance innovation in nasal drug delivery systems.
In recent years, the pharmaceutical industry has witnessed a renewed focus on nasal delivery technologies—both in traditional therapeutic applications and in emerging areas such as mucosal vaccines, CNS therapies, and rapid systemic delivery products. In this evolving landscape, nasal platforms are increasingly recognized for their versatility and their ability to enhance speed of action, patient compliance, and treatment accessibility.
In recent years, the pharmaceutical industry has witnessed a renewed focus on nasal delivery technologies—both in traditional therapeutic applications and in emerging areas such as mucosal vaccines, CNS therapies, and rapid systemic delivery products. In this evolving landscape, nasal platforms are increasingly recognized for their versatility and their ability to enhance speed of action, patient compliance, and treatment accessibility.
The Nasal Innovation Forum offers a strategic opportunity to explore the dynamics propelling this rapidly expanding segment. The two-day program will address critical topics including:  
  • The evolution of global regulatory requirements for nasal products
  • Innovations in characterization techniques and analytical methods
  • Formulation and device development strategies
  • Considerations for manufacturing, stability, and quality
  • Preclinical and clinical approaches to optimizing therapeutic outcomes
 
The Nasal Innovation Forum offers a strategic opportunity to explore the dynamics propelling this rapidly expanding segment. The two-day program will address critical topics including:  
  • The evolution of global regulatory requirements for nasal products
  • Innovations in characterization techniques and analytical methods
  • Formulation and device development strategies
  • Considerations for manufacturing, stability, and quality
  • Preclinical and clinical approaches to optimizing therapeutic outcomes
 
  Sterling will participate with a team of experts to contribute to the dialogue on scientific and regulatory challenges, sharing its expertise in the end-to-end development of nasal products—from preclinical studies through to commercial-scale manufacturing. Our involvement in this forum underscores Sterling’s ongoing commitment to fostering innovation and supporting the technological advancement of the pharmaceutical sector.   DOWNLOAD THE PROGRAM HERE!
  Sterling will participate with a team of experts to contribute to the dialogue on scientific and regulatory challenges, sharing its expertise in the end-to-end development of nasal products—from preclinical studies through to commercial-scale manufacturing. Our involvement in this forum underscores Sterling’s ongoing commitment to fostering innovation and supporting the technological advancement of the pharmaceutical sector.   DOWNLOAD THE PROGRAM HERE!